These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 4284319)

  • 1. [On the soluble fraction of Bordetella pertussis isolated with sodium desoxycholate].
    Soare I; Barber C; Dumitresco M
    Arch Roum Pathol Exp Microbiol; 1964 Dec; 23(4):839-44. PubMed ID: 4284319
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunohistological studies of mice infected with bordetella pertussis.
    Kawahira M; Yoshioka M; Nishiyama Y; Saito Y; Kawkubo Y
    Kitasato Arch Exp Med; 1968 Jun; 41(1):1-9. PubMed ID: 4308582
    [No Abstract]   [Full Text] [Related]  

  • 3. Serological types of whooping cough bacteria and their connection with immunity in vaccinated children.
    Demina AA; Devyatkina NP; Voloshina LZ; Larina LI; Semina NA; Venglinskaya EA; Kostyukova KP
    J Hyg Epidemiol Microbiol Immunol; 1973 Mar; 17(3):304-15. PubMed ID: 4355335
    [No Abstract]   [Full Text] [Related]  

  • 4. [Immunological studies with the desoxycholate extract of Bordetella pertussis according to Barta].
    Milleck J
    Z Immunitatsforsch Allerg Klin Immunol; 1966 Jun; 130(5):461-9. PubMed ID: 4294232
    [No Abstract]   [Full Text] [Related]  

  • 5. Vaccination against pertussis.
    Evans DG
    Mem Acad R Med Belg; 1972 Mar; 7(6):447-53. PubMed ID: 4339774
    [No Abstract]   [Full Text] [Related]  

  • 6. Soluble protective antigen from Bordetella pertussis prepared with sodium desoxycholate.
    BARTA G
    J Immunol; 1963 Jan; 90():72-80. PubMed ID: 13969631
    [No Abstract]   [Full Text] [Related]  

  • 7. Is pertussis a frequent cause of cough in adolescents and adults? Should routine pertussis immunization be recommended?
    Edwards KM
    Clin Infect Dis; 2001 Jun; 32(12):1698-9. PubMed ID: 11360209
    [No Abstract]   [Full Text] [Related]  

  • 8. Lung pathology and immediate hypersensitivity in a mouse model after vaccination with pertussis vaccines and challenge with Bordetella pertussis.
    Vandebriel RJ; Gremmer ER; Vermeulen JP; Hellwig SM; Dormans JA; Roholl PJ; Mooi FR
    Vaccine; 2007 Mar; 25(12):2346-60. PubMed ID: 17224216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immunogenic value of the diphtheria-tetanus-pertussis trivaccine depending on the quantitative variations of its antigenic components. IV. Immunogenic properties of the pertussis compound].
    Andreescu V; Caffé I; Marion M; Pozsgi N; Stănică E; Stoian C; Kranzdorf H
    Arch Roum Pathol Exp Microbiol; 1970 Sep; 29(3):487-92. PubMed ID: 4328575
    [No Abstract]   [Full Text] [Related]  

  • 10. Studies on the circulation of bordetella pertussis and bordetella parapertussis in populations of children.
    Borská K; Simkovicová M
    J Hyg Epidemiol Microbiol Immunol; 1972; 16(2):159-72. PubMed ID: 4339092
    [No Abstract]   [Full Text] [Related]  

  • 11. Population dynamics of Bordetella pertussis in Finland and Sweden, neighbouring countries with different vaccination histories.
    Elomaa A; Advani A; Donnelly D; Antila M; Mertsola J; He Q; Hallander H
    Vaccine; 2007 Jan; 25(5):918-26. PubMed ID: 17030495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant and immunogenic activities of the 73kDa N-terminal alpha-domain of BrkA autotransporter and Cpn60/60kDa chaperonin of Bordetella pertussis.
    Cainelli Gebara VC; Risoléo L; Lopes AP; Ferreira VR; Quintilio W; Lépine F; Silva WD; Raw I
    Vaccine; 2007 Jan; 25(4):621-9. PubMed ID: 17011680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative analysis of a Bordetella pertussis patient isolated strain and classical strains used in the pertussis vaccine.
    Pereira A; Pereira AS; Moreira-Filho CA; Bando SY; Tambourgi DV
    Vaccine; 2005 Jul; 23(34):4353-8. PubMed ID: 16005744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of outbreak and vaccine strains of Bordetella pertussis--Quebec.
    Knowles K; Lorange M; Matthews RC; Preston NW
    Can Commun Dis Rep; 1993 Nov; 19(21):182-3, 186-7. PubMed ID: 8298581
    [No Abstract]   [Full Text] [Related]  

  • 15. [Whooping cough--time to reconsider the vaccination program].
    Hallander HO
    Lakartidningen; 2015 Jun; 112():. PubMed ID: 26103576
    [No Abstract]   [Full Text] [Related]  

  • 16. [Pertussis. Critical revision of its physiopathology. Implications].
    Fiore D
    Pediatr Med Chir; 1996; 18(1):109-12. PubMed ID: 8685015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The altered reactivity of mice after inoculation with Bordetella pertussis vaccine.
    KIND LS
    Bacteriol Rev; 1958 Sep; 22(3):173-82. PubMed ID: 13572280
    [No Abstract]   [Full Text] [Related]  

  • 18. [Monitoring of a whooping cough epidemic 1994/95 in Switzerland using the sentinel notification system. Sentinella Registry].
    Matter HC; Schmidt-Schläpfer G; Zimmermann H
    Schweiz Med Wochenschr; 1996 Aug; 126(34):1423-32. PubMed ID: 8848704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [On tissue reactivity during experimental infection and immunization with Bordetella pertussis].
    Ciplea AG; Pozsgi N
    Arch Roum Pathol Exp Microbiol; 1970 Dec; 29(4):719-24. PubMed ID: 5521124
    [No Abstract]   [Full Text] [Related]  

  • 20. [The effect of prophylactic whooping-cough vaccination. An attempt at an evaluation based on experiences in Denmark].
    Lautrop H; Mikkelsen OS
    Ugeskr Laeger; 1969 Apr; 131(17):735-41. PubMed ID: 4307508
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.